GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-20 EDT			5-day change	1st Jan Change
79.44 ^USD	+1.49%		+3.18%	+2.74%

06-20	GE HealthCare, MediView Report Clinical Use of OmnifyXR Interventional Suite	MT
06-20	GE Healthcare and Mediview Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite That Aims to Transform the Practice of Interventional Radiology	CI

Nucleus RadioPharma, Inc. announced that it has received $66.099956 million in funding from a group of investors

June 04, 2024

On June 5, 2024, Nucleus RadioPharma, Inc. closed the transaction. The company has received a round of funding from new investor, AstraZeneca PLC. As apart of the transaction, Tyrell Rivers of AstraZeneca PLC will join the company board of directors.

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	ASTRAZENECA PLC	12,398 GBX	+0.47%	+0.05%	244B
	GE HEALTHCARE TECHNOLOGIES INC.	79.44 USD	+1.49%	+3.18%	36.26B

Latest news about GE HealthCare Technologies Inc.

GE HealthCare, MediView Report Clinical Use of OmnifyXR Interventional Suite	06-20	MT
GE Healthcare and Mediview Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite That Aims to Transform the Practice of Interventional Radiology	06-20	CI
GE HealthCare Reports Changes in Key Segments	06-10	MT
GE Healthcare Technologies Inc. Announces Management Changes	06-10	CI
Transcript : GE HealthCare Technologies Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:00 AM	06-05
Nucleus RadioPharma, Inc. announced that it has received $66.099956 million in funding from a group of investors	06-04	CI
GE HealthCare, Tampa General Hospital Expand Collaboration in Imaging, Ultrasound Technology	05-30	MT
GE Healthcare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida	05-30	CI
Goldman Sachs Initiates GE HealthCare Technologies With Neutral Rating, $87 Price Target	05-30	MT
GE Healthcare Names Adam Holton as Chief People Officer	05-29	CI
Some of the biggest splits in Corporate America	05-23	RE
GE HealthCare Technologies Insider Sold Shares Worth $7,109,427, According to a Recent SEC Filing	05-16	MT
Transcript : GE HealthCare Technologies Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:00 AM	05-14
GE Healthcare and Medis Medical Imaging Announces Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease	05-14	CI
GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science	05-05	CI
Mizuho Adjusts Price Target on GE HealthCare Technologies to $105 From $110	05-01	MT
GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress	05-01	CI
Jefferies Adjusts Price Target on GE HealthCare Technologies to $87 From $92	05-01	MT
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	04-30	DJ
Equity Markets Slide Ahead of Fed Rate Decision	04-30	MT
Equity Markets Drop Ahead of Fed Rate Decision	04-30	MT
Sector Update: Health Care Stocks Mixed Late Afternoon	04-30	MT
Equity Markets Down Ahead of Amazon Earnings	04-30	MT
Top Midday Decliners	04-30	MT
Wells Fargo Cuts GE HealthCare Technologies' Price Target to $88 From $90	04-30	MT

Chart GE HealthCare Technologies Inc.

Duration

Period

More charts

Company Profile

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-22 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for GE HealthCare Technologies Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

79.44 USD

Average target price

92.74 USD

Spread / Average Target

+16.74%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
GE HEALTHCARE TECHNOLOGIES INC.	+2.74%	36.26B
THERMO FISHER SCIENTIFIC	+4.98%	213B
DANAHER CORPORATION	+7.44%	184B
INTUITIVE SURGICAL, INC.	+28.22%	153B
BOSTON SCIENTIFIC CORPORATION	+33.19%	113B
SIEMENS HEALTHINEERS AG	+1.22%	63.66B
EDWARDS LIFESCIENCES CORPORATION	+16.51%	53.53B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+1.45%	49.11B
AGILENT TECHNOLOGIES, INC.	-4.53%	38.73B
RESMED, INC.	+23.98%	31.33B

Other Advanced Medical Equipment & Technology